Efficacy of EMDR Versus CBT for Post-Traumatic Stress Disorder in Pakistan
Key facts
- Who runs it
- Khushal Khan Khattak Univeristy, Karak, Pakistan
- Where
- Pakistan3 sites in 1 countryChoose a country to see its sites
- Trial code
- Status
- Completed
- People taking part
- 80 people enrolled
- Started
- 10 May 2022
- Ended
- 1 Mar 2024
- Type of study
- Interventional, 2 groupsOne group gets an existing treatment, for comparison.
- Treatments tested
- Eye Movement Desensitization and Reprocessing (EMDR) Therapy
- Cognitive Behavioral Therapy (CBT)
- Record updated
- 29 September 2026
Who can take part
- Age
- 15 years to 60 years
- Sex
- Women and men
- Healthy volunteers
- Cannot take part
The registry criteria, word for word
Show all 10 criteriaShow less
Who can take part
- Aged 15 to 60 years
- Confirmed diagnosis of post-traumatic stress disorder (PTSD), with PTSD identified as the primary clinical condition
- Associated symptoms of depression and anxiety at screening
- Able to participate in face-to-face psychotherapy and perform the basic eye and hand movements required for the treatment procedures
- Able to provide informed consent and communicate sufficiently to participate meaningfully in assessment and psychotherapy
Who cannot take part
- Does not meet the screening criteria for PTSD, or PTSD is not the primary clinical condition
- Severe intellectual impairment that substantially limits the ability to understand, communicate, or participate in the assessment and psychotherapy procedures
- Younger than 15 years or older than 60 years
- Significant limitations in eye or hand movement, or inability to perform the basic movements required for participation in the treatment procedures
- Prolonged unconsciousness or otherwise unable to maintain sufficient consciousness to participate meaningfully in assessment or psychotherapy
Where is this trial?
It has sites in one country. Choose a country to see its sites.
About the trial
What the trial wants to find out
This randomized controlled trial compares Eye Movement Desensitization and Reprocessing (EMDR) therapy with Cognitive Behavioral Therapy (CBT) for the treatment of post-traumatic stress disorder (PTSD) in Pakistan. The study examines whether EMDR is at least as effective as CBT in reducing PTSD symptoms over time. It also assesses changes in symptoms of depression and anxiety that commonly occur alongside PTSD. Participants are randomly assigned to receive either EMDR or CBT, and their symptoms are assessed at different stages of treatment and follow-up.
The 2 groups in the trial
- Eye Movement Desensitization and Reprocessing (EMDR) TherapyTreatment being tested
Participants assigned to this arm received face-to-face Eye Movement Desensitization and Reprocessing (EMDR) therapy delivered by clinical psychologists trained in EMDR. Treatment followed an eight-stage EMDR protocol for PTSD, with culturally adapted procedures used where appropriate. The number of sessions varied according to symptom severity and clinical need, generally ranging from 6 to 14 sessions, typically delivered once per week. PTSD, depressive, and anxiety symptoms were assessed at baseline, during treatment, at the end of treatment, and at follow-up
- Cognitive Behavioral Therapy (CBT)Existing treatment, for comparison
Participants assigned to this arm received face-to-face Cognitive Behavioral Therapy (CBT) delivered by clinical psychologists trained in CBT. Treatment followed a structured trauma-focused CBT protocol, with culturally adapted procedures used where appropriate. The number of sessions varied according to symptom severity and clinical need, generally ranging from 6 to 14 sessions, typically delivered once per week. PTSD, depressive, and anxiety symptoms were assessed at baseline, during treatment, at the end of treatment, and at follow-up.
Data and sources
- Registry record
- Listed on ClinicalTrials.gov.How to verify a trial in the registry
- Official title
- Efficacy of Eye Movement Desensitization and Reprocessing Versus Cognitive Behavioral Therapy for Post-Traumatic Stress Disorder and Comorbid Disorders in Pakistan: A Full-Fledged Randomized Controlled Trial
- Record updated
- 29 September 2026